Keyphrases
Signaling Mechanism
100%
Acid Activation
100%
Lysophosphatidic Acid
100%
Ovarian Cancer Cells
100%
Urokinase-type Plasminogen Activator
100%
NF-B
36%
Dominant Negative
36%
HEC-RAS
27%
Binding Site
18%
Signaling Pathway
18%
Signaling Molecules
18%
MEK1
18%
RAF1
18%
Promoter Activation
18%
Inhibitory Effect
9%
Molecular Mechanism
9%
Constitutively Active
9%
Ovarian Cancer
9%
ERK2
9%
Knock
9%
Signaling Cascades
9%
Specific Inhibitor
9%
Over 80
9%
SKOV3
9%
Negative Type
9%
Medicine and Dentistry
Cancer Cell
100%
Signaling Mechanism
100%
Ovarian Cancer
100%
Lysophosphatidic Acid
100%
Urokinase
100%
Ras Signaling
54%
Upregulation
45%
Promoter Region
36%
Signaling Molecule
18%
Binding Site
18%
Phosphotransferase
9%
Signal Transduction
9%
Cell Signaling Pathway
9%
Knock Out
9%
SK-OV-3 Cell Line
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Signaling Mechanism
100%
Lysophosphatidic Acid
100%
Urokinase
100%
Upregulation
45%
Promoter Region
36%
Binding Site
18%
Signal Transduction
9%
Kinase
9%
Phosphotransferase
9%
Immunology and Microbiology
Cancer Cell
100%
Upregulation
100%
Signaling Mechanism
100%
Promoter Region
80%
Binding Site
40%
Signal Transduction
20%
SK-OV-3 Cell Line
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Lysophosphatidic Acid
100%
Urokinase
100%
Binding Site
18%
Phosphotransferase
9%